Gennex Laboratories Ltd

Gennex Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Gennex Laboratories Ltd

₹ 10.8 2.96%
22 Jun 2:17 p.m.
gennexlab.com BSE: 531739
About

Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]

Key Points

Business Overview:[1][2]
GLL is an ISO 9001:2008, TUV, ISO 14001 and OSHAS 18000 certified vertically integrated Active Pharmaceutical Ingredient manufacturer & exporter of Bulk Drugs, Intermediates and Biotech Products in the form of Expectorants,
Muscle Relaxants, Analgesic and Anti Fungal, etc.

Website BSE
  • Market Cap ₹ 262 Cr.
  • Current Price ₹ 10.8
  • High / Low ₹ 17.2 / 7.05
  • Stock P/E 13.9
  • Book Value ₹ 9.16
  • Dividend Yield 0.00 %
  • ROCE 10.8 %
  • ROE 9.25 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Stock is trading at 1.19 times its book value
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 34.4% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 23.6%
  • Tax rate seems low
  • Company has a low return on equity of 9.82% over last 3 years.
  • Debtor days have increased from 68.2 to 92.0 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
20.80 16.52 18.18 21.39 35.52 28.32 33.38 40.01 40.33 34.18 39.30 42.96 60.96
17.28 11.42 12.41 16.59 29.26 24.10 25.92 32.86 38.31 29.11 31.74 34.39 55.07
Operating Profit 3.52 5.10 5.77 4.80 6.26 4.22 7.46 7.15 2.02 5.07 7.56 8.57 5.89
OPM % 16.92% 30.87% 31.74% 22.44% 17.62% 14.90% 22.35% 17.87% 5.01% 14.83% 19.24% 19.95% 9.66%
0.00 0.00 0.00 0.00 0.00 2.47 0.00 0.00 3.68 2.28 0.00 -0.30 1.02
Interest 0.63 0.73 0.78 0.83 0.73 0.73 0.22 0.84 1.20 0.98 1.03 1.11 1.08
Depreciation 0.37 0.65 1.03 0.45 0.23 0.45 1.11 0.50 0.54 0.50 0.47 0.52 1.16
Profit before tax 2.52 3.72 3.96 3.52 5.30 5.51 6.13 5.81 3.96 5.87 6.06 6.64 4.67
Tax % 19.05% 23.39% 22.47% 21.31% 15.28% 15.43% 12.23% 12.91% 22.22% 14.48% 9.08% 9.79% 4.50%
2.04 2.85 3.07 2.76 4.50 4.66 5.38 5.06 3.07 5.01 5.51 6.00 4.46
EPS in Rs 0.12 0.16 0.17 0.15 0.20 0.19 0.21 0.20 0.10 0.20 0.21 0.22 0.15
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
42 44 56 56 60 61 66 87 138 173
37 42 52 52 53 56 61 70 121 150
Operating Profit 5 2 4 3 7 5 5 17 17 22
OPM % 11% 5% 7% 6% 11% 9% 7% 20% 12% 13%
0 1 1 1 0 1 4 5 10 8
Interest 1 1 1 1 1 1 1 3 4 4
Depreciation 1 1 1 1 1 1 1 2 2 3
Profit before tax 3 1 3 3 5 5 6 16 21 23
Tax % 13% 42% 26% 27% 20% 23% 23% 20% 15% 10%
3 1 2 2 4 4 5 13 18 21
EPS in Rs 0.14 0.04 0.12 0.10 0.21 0.21 0.28 0.58 0.80 0.76
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 24%
3 Years: 38%
TTM: 25%
Compounded Profit Growth
10 Years: %
5 Years: 34%
3 Years: 57%
TTM: 4%
Stock Price CAGR
10 Years: 5%
5 Years: 3%
3 Years: 15%
1 Year: -15%
Return on Equity
10 Years: 9%
5 Years: 10%
3 Years: 10%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 13 13 13 13 13 13 18 23 23 24
Reserves 18 19 21 23 27 31 62 148 164 198
4 2 5 5 7 10 1 6 10 79
14 16 13 16 12 14 51 54 59 47
Total Liabilities 49 50 52 57 59 68 132 230 256 349
16 16 16 15 14 14 74 56 60 61
CWIP 0 0 0 0 0 0 0 2 5 13
Investments 7 7 7 7 7 7 0 0 0 0
26 28 29 35 38 48 59 172 191 275
Total Assets 49 50 52 57 59 68 132 230 256 349

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0 3 2 -2 -1 12 24 -47 -11 -64
-1 -1 -1 -0 -0 -2 -38 19 1 -5
1 -2 1 -0 2 -2 21 74 5 65
Net Cash Flow -0 0 2 -2 0 8 6 46 -5 -3
Free Cash Flow -1 2 1 -2 -2 10 -16 -31 -20 -76
CFO/OP 13% 190% 55% -52% 1% 242% 505% -274% -45% -274%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 90 87 68 41 55 67 52 75 37 92
Inventory Days 43 31 57 78 50 72 139 184 133 153
Days Payable 139 161 88 86 59 72 63 111 49 58
Cash Conversion Cycle -7 -43 38 34 46 67 129 148 122 187
Working Capital Days 74 75 56 87 108 87 23 255 214 295
ROCE % 6% 11% 8% 14% 12% 11% 14% 13% 11%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Employees
Numbers ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Trade Receivables Turnover Ratio
Ratio ・Standalone data
Actual Production Volume
TPA ・Standalone data
Installed Capacity
TPA ・Standalone data
WHO-GMP Approved Products
Numbers ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

3 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
23.38% 23.61% 23.61% 18.41% 18.41% 18.41% 18.41% 18.41% 19.82% 23.62% 23.62% 23.63%
76.62% 76.39% 76.39% 81.58% 81.57% 81.59% 81.58% 81.58% 80.17% 76.38% 76.39% 76.36%
No. of Shareholders 52,98150,98869,72383,99687,82090,23692,50692,32691,18390,32086,30684,133

Documents

Announcements

Annual reports

Right Issue